Roche hit by loss of Tamiflu sales
ZURICH (Reuters) - Roche Holding AG, Europe's largest drugmaker by market value, posted first-quarter sales up 2 percent in local currencies to 10.9 billion Swiss francs ($10.86 billion), hit by loss of pandemic Tamiflu sales, and missing forecasts.
<p><img src="http://feeds.reuters.com/~a/reuters/businessNews?i=ZcCX7j" border="0"></img> (http://feeds.reuters.com/~a/reuters/businessNews?a=ZcCX7j)</p><div class="feedflare">
<img src="http://feeds.reuters.com/~f/reuters/businessNews?i=ZfhFVQG" border="0"></img> (http://feeds.reuters.com/~f/reuters/businessNews?a=ZfhFVQG) <img src="http://feeds.reuters.com/~f/reuters/businessNews?i=BSyuqsg" border="0"></img> (http://feeds.reuters.com/~f/reuters/businessNews?a=BSyuqsg) <img src="http://feeds.reuters.com/~f/reuters/businessNews?i=YuQKe8g" border="0"></img> (http://feeds.reuters.com/~f/reuters/businessNews?a=YuQKe8g)
</div><img src="http://feeds.reuters.com/~r/reuters/businessNews/~4/271947031" height="1" width="1"/>
http://feeds.reuters.com/~r/reuters/businessNews/~3/271947031/idUSL1786942920080417